Healthcare entity
funding is the sole category represented across all 1 tracked stories. BioFlorida is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 5.9.
Last mentioned: Mar 10, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
funding is the sole category represented across all 1 tracked stories. BioFlorida is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 5.9. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. NMIIA/IIB inhibitor appears in 1 tracked Healthcare story from March 10, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 39 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NMIIA/IIB inhibitor. Shared-story counts are live from our verified record — not editorial picks.
BioFlorida Showcase
Cornerstone Session presentation on innovation in the regional ecosystem.
Investival Showcase
Presentation at the South Florida Rising Life Science Hub event.
Conference Invitations
Announced invitations to two major South Florida life sciences showcases.
National Partnering
Presented at BioCom California Global Life Science Partnering Conference.
Myosin Therapeutics has been selected to present its first-in-class nanomotor-dependency platform at two major South Florida life sciences conferences in March 2026. The company is advancing MT-125, a dual NMIIA/IIB inhibitor currently in Phase 1/2 trials for glioblastoma, targeting the physical mechanics of cancer cells to bypass traditional resistance.
Source: prnewswire.com · admin (in)
NMIIA/IIB inhibitor is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
